YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Centene (CNC) one of those stocks right now? Let's take a closer look at the stock's year-to-date pe…
* Alzamend Neuro (ALZN [https://seekingalpha.com/symbol/ALZN]) received [https://seekingalpha.com/pr/20653272-alzamend-neuro-regains-compliance-with-nasdaq-listing-standards] a notification letter from Nasdaq dated September 14, 2026, info…
(RTTNews) - Alzamend Neuro, Inc. (ALZN), Thursday announced positive topline data from its first Phase II 'Lithium in Brain' clinical trial. The trial showed that AL001 meets bioequivalence standards while also showing numerically superior…
Embecta Corp. EMBC is set to release fourth-quarter fiscal 2025 results on Nov. 25, before the market opens. Here’s a brief review of the company’s performance leading up to this announcement. Factors That Might Have Shaped EMBC’s Q4 Perfo…
We recently published a list of 15 Cheapest Stocks Insiders Are Buying In March. In this article, we are going to take a look at where Alzamend Neuro, Inc. (NASDAQ:ALZN) stands against other cheapest stocks insiders are buying in March. Af…
ATLANTA, March 04, 2025 (GLOBE NEWSWIRE) -- Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease (“Alzheimer’s”), bipolar…
ATLANTA, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease (“Alzheimer’s”), bipolar…
In this article, we will take a detailed look at Insiders Are Buying These 11 Penny Stocks. For a quick overview of such stocks, read our article Insiders Are Buying These 5 Penny Stocks. US stock market started the second quarter of 2024…
Developing groundbreaking drugs and devices entails high costs, uncertain regulatory approval, and lucrative revenues. Those factors and more culminate to create a sector filled with dozens of biotech stocks that have 10X potential, or bet…
Turning $1,000 into $10,000 in a year in the stock market is undoubtedly a lofty goal. Make no bones about it, it’s not particularly likely to happen. Indeed, such an endeavor requires a penchant for risk and speculation. Additionally, inv…
In this article, we discuss the 10 biotech stocks with the biggest upside. If you want to read about some more biotech stocks with the biggest upside, go directly to 5 Biotech Stocks With The Biggest Upside. The biotechnology sector has be…
Investors in penny stocks know that they are an inherently risky proposition. That goes double for any investor just getting into this market. But with great risk comes great reward. In this case, I think these are penny stocks with 1,000%…
In this article, we discuss the 10 best biotech penny stocks to buy now. If you want to skip our detailed analysis of the biotech sector, go directly to 5 Best Biotech Penny Stocks To Buy Now. Like all sectors of the economy right now, the…
In this article, we discuss 10 biotech penny stocks that Redditors love. If you want to read about some more biotech stocks popular on Reddit, go directly to 5 Biotech Penny Stocks Redditors Love. The bull market around the biotech sector…
In this article, we discuss 10 biotech penny stocks with growth catalysts. If you want to see some more stocks in this selection, check out 5 Biotech Penny Stocks with Growth Catalysts. According to Global Market Insights, the market for b…
Galera Therapeutics (NASDAQ:GRTX) stock is rocketing higher on Tuesday after the cancer treatment company revealed corrected results from a Phase 3 clinical trial. colorful pills and vials sitting on a table representing GRTX Stock. Source…
LAS VEGAS, November 19, 2021--(BUSINESS WIRE)--Ault Global Holdings, Inc. (NYSE American: DPW) a diversified holding company (the "Company"), today announced its financial results for the three and nine months ended September 30, 2021. Nin…
Gainers Fossil Group, Inc. (NASDAQ: FOSL) rose 33.8% to $18.52 in pre-market trading after the company reported better-than-expected Q3 sales results and raised FY21 net sales growth guidance. Affirm Holdings, Inc. (NASDAQ: AFRM) rose 27.7…
Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares climbed 198.4% to $14.92. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the middle of the estimated price range of $4-$6, for raising gross proceeds of $…
Gainers Biomerica, Inc. (NASDAQ: BMRA) shares surged 38% to close at $6.21 on Friday. Biomerica entered into a Supplier Agreement with Walmart to sell its EZ Detect colorectal disease screening test within the Walmart retail system. Exscie…
Gainers Biomerica, Inc. (NASDAQ: BMRA) shares climbed 38.3% to $6.23. Biomerica entered into a Supplier Agreement with Walmart to sell its EZ Detect colorectal disease screening test within the Walmart retail system. Progenity, Inc. (NASDA…
Paychex, Inc.’s PAYX shares rose 4.3% after the company reported first-quarter of fiscal 2022 earnings of 89 cents per share, surpassing the Zacks Consensus Estimate of 81 cents. Shares of Virgin Galactic Holdings, Inc. SPCE surged 12.2% a…
Gainers Superior Drilling Products, Inc. (NYSE: SDPI) shares rose 60.6% to close at $1.75 on Thursday after jumping over 23% on Wednesday. The company, last month, reported Q2 earnings of $0.00 per share on sales of $3.40 million. Progenit…
Gainers Paltalk, Inc. (NASDAQ: PALT) shares jumped 55% to $13.00. Paltalk engaged ClearThink to lead expanded investor relations program. Farmmi, Inc. (NASDAQ: FAMI) jumped 45.5% to $0.4945 after surging over 41% on Wednesday. Farmmi issue…
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29) Acceleron Pharma Inc. (NASDAQ: XLRN) Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) Innoviva, I…
By John Vandermosten, CFA NASDAQ:ALZN | NASDAQ:BIIB Alzamend Neuro, Inc. (NASDAQ:ALZN) is an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative and psychiatric disorde…
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC) aTyr Pharma, Inc. (NASDAQ: LIFE) (reacted to positive analyst action…
Q2 2021 Revenue of $62.1 Million, up 1050% From the Prior Year’s Quarter Q2 2021 Net Income of $42.2 Million Compared to a $1.4 Million Loss in the Prior Year’s Quarter Total Assets of More Than a Quarter of a Billion Dollars ($259.1 Milli…
LAS VEGAS, August 04, 2021--(BUSINESS WIRE)--Ault Global Holdings, Inc. (NYSE American: DPW), a diversified holding company (the "Company"), announced today its wholly owned subsidiary, Digital Power Lending, LLC ("DPL") has made an additi…
Q2 2021 Revenue of Approximately $62 million, up 1048% From the Prior Year’s Quarter Q2 2021 Income Before Taxes of Approximately $44 Million Compared to a $1.4 Million Loss in the Prior Year’s Quarter LAS VEGAS, July 13, 2021--(BUSINESS W…
LAS VEGAS, July 01, 2021--(BUSINESS WIRE)--Ault Global Holdings, Inc. (NYSE American: DPW) a diversified holding company (the "Company"), announced today that Alzamend Neuro, Inc. (Nasdaq: ALZN) ("Alzamend"), a preclinical stage biopharmac…
LAS VEGAS, July 01, 2021--(BUSINESS WIRE)--Ault Global Holdings, Inc. (NYSE American: DPW) a diversified holding company (the "Company"), announced today that Alzamend Neuro, Inc. (Nasdaq: ALZN) ("Alzamend"), a preclinical stage biopharmac…
LAS VEGAS, Jun 16, 2021--(BUSINESS WIRE)--Ault Global Holdings, Inc. (NYSE American: DPW), a diversified holding company (the "Company"), announced today that Alzamend Neuro, Inc. (Nasdaq: ALZN) ("Alzamend"), a preclinical stage biopharmac…
LAS VEGAS, Jun 16, 2021--(BUSINESS WIRE)--Ault Global Holdings, Inc. (NYSE American: DPW), a diversified holding company (the "Company"), announced today that Alzamend Neuro, Inc. (Nasdaq: ALZN) ("Alzamend"), a preclinical stage biopharmac…